CCP
ALXN

Corient Capital Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Corient Capital Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
2021
Q2 		$551K Buy
2021
Q1 		$420K Buy
2020
Q4 		$369K Buy
2020
Q3 		$212K Sell
2020
Q2 		$225K Buy
2019
Q4 		– Sell
2019
Q3 		$822K Buy